Impact of racial disparities and insurance status in patients with bone sarcomas in the USA | Bone & Joint
Impact of racial disparities and insurance status in patients with bone sarcomas in the USA
Related Articles
QoC
Register for free learning The workup and management of patients with Giant Cell Arteritis In this upcoming webinar on vasculitis, Christina Ponte, Christian Dejaco, and…
SECEC Grammont Award 2024: The critical role of posture adjustment for range of motion simulation in reverse total shoulder arthroplasty preoperative planning | Bone & Joint
SECEC Grammont Award 2024: The critical role of posture adjustment for range of motion simulation in reverse total shoulder arthroplasty preoperative planning
Modified Frailty Index as a novel predictor for the incidence and severity of postoperative complications after spinal metastases surgery | Bone & Joint
Modified Frailty Index as a novel predictor for the incidence and severity of postoperative complications after spinal metastases surgery
The core outcomes for open lower limb fracture study | Bone & Joint
The core outcomes for open lower limb fracture study
Quadruple Disruption of Superior Shoulder Suspensory Complex With Proximal Humerus Open Fracture-Dislocation
A 34-year-old man was a restrained passenger involved in a high-speed rollover motor vehicle crash. The patient sustained a type 5 AC joint separation, severely…
Intraoperative Hypotension Is an Important Modifiable Risk… : Spine
is associated with postoperative acute kidney injury (AKI) in general surgery. In spinal deformity surgery, IOH is a contributing factor to MEP changes and spinal…
Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes at Two Years after VITAL Trial Completion
Objective In the 5.3 year randomized, 2 x 2 factorial, double-blind, placebo-controlled VITamin D and OmegA-3 TriaL (VITAL), vitamin D supplementationreduced autoimmune disease (AD) incidence…
Improvements in Patient‐Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial
Objective Deucravacitinib, a tyrosine kinase 2 inhibitor, was assessed in a phase 2 trial in patients with active psoriatic arthritis (PsA). Here, we report effects…
Home | Miller’s Orthopaedic Review Course Oxford
Oxford Comprehensive Orthopaedic Review Course is a 7 day course specifically designed for those who are preparing to sit the FRCS (Tr & Orth) examination.